☆ 4.8 Article

Self-Degradable Nanogels Reshape Immunosuppressive Tumor Microenvironment via Drug Repurposing Strategy to Reactivate Cytotoxic CD8+ T Cells

ADVANCED SCIENCE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Gastroenterology & Hepatology

Global prediction of primary liver cancer incidences and mortality in 2040

Chenxi Li et al.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy

Hao Tian et al.

Summary: A phenolic nanoadjuvant has been developed to enhance the maturation of dendritic cells (DCs) and improve the efficacy of cancer immunotherapy. This nanoadjuvant promotes the activation of the cGAS-STING pathway and sensitizes tumors to PD-L1 checkpoint blockade immunotherapy, resulting in inhibiting tumor growth and restraining lung metastasis.

NANO TODAY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis

Xin Guan et al.

Summary: Surgical resection often leads to tumor recurrence, impacting clinical outcomes. Novel nanosystem utilizing manganese dioxide shows promise in reducing cancer recurrence and metastasis post-surgery by targeting myeloid cells and relieving tumor hypoxia, ultimately enhancing response to radio-immunotherapy.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Oncology

Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer

Joyeon Kang et al.

Summary: Metformin has been found to decrease the fractions of MDSCs and M2 macrophages in the tumor microenvironment by activating AMPK and inhibiting mTOR, thus playing a potential role in the prevention and treatment of colorectal cancer.

CANCERS (2022)

添加到收藏夹

Article Oncology

Bystander T cells in cancer immunology and therapy

Stefanie L. Meier et al.

Summary: Bystander T cells play a crucial role in tumor immunology, with their diverse specificities, activation states, and effector functions offering potential insights for the development of new therapeutic approaches in cancer immunotherapy. Despite their importance, the understanding of bystander T cells in tumors is still in its early stages, highlighting the need for further research in this area.

NATURE CANCER (2022)

添加到收藏夹

Review Oncology

Cytotoxic CD8+T cells in cancer and cancer immunotherapy

Hans Raskov et al.

Summary: The functions and interactions between the innate and adaptive immune systems play a crucial role in anticancer immunity. Cytotoxic T cells with CD8 as the most effective effectors in the anticancer immune response form the basis of successful cancer immunotherapies. Advancements in genetically modified or synthetic receptors on cytotoxic T cells are being developed for future cancer treatment. Combinatory regimens may optimize treatment effects and reduce adverse events in cancer therapy.

BRITISH JOURNAL OF CANCER (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

Zhaohan Wei et al.

Summary: This study demonstrates that metformin-loaded mannose-modified macrophage-derived microparticles can reprogram the tumor immune microenvironment, enhance responses to anti-PD-1 therapy, and promote infiltration of CD8(+) T cells into tumor tissues.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Review Cell Biology

The multifaceted effects of metformin on tumor microenvironment

Ivana Kurelac et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)

添加到收藏夹

Article Oncology

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

John D. Martin et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial

Shuhong Wang et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Review Immunology

Opportunities for Small Molecules in Cancer Immunotherapy

Sabina Y. van der Zanden et al.

TRENDS IN IMMUNOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The updated landscape of tumor microenvironment and drug repurposing

Ming-Zhu Jin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

添加到收藏夹

Article Oncology

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

Sha Zhao et al.

CANCER IMMUNOLOGY RESEARCH (2019)

添加到收藏夹

Review Immunology

T Cell Dysfunction in Cancer Immunity and Immunotherapy

Anliang Xia et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Oncology

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy

Sara Verdura et al.

ONCOIMMUNOLOGY (2019)

添加到收藏夹

Review Cell Biology

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

Bagher Farhood et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Jong-Ho Cha et al.

MOLECULAR CELL (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Drug repurposing in cancer

Linda Sleire et al.

PHARMACOLOGICAL RESEARCH (2017)

添加到收藏夹

Article Multidisciplinary Sciences

H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay

Qian Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

添加到收藏夹

Review Oncology

Combination cancer immunotherapies tailored to the tumour microenvironment

Mark J. Smyth et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Chemistry, Multidisciplinary

Intelligent Albumin-MnO2 Nanoparticles as pH-/H2O2-Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy

Qian Chen et al.

ADVANCED MATERIALS (2016)

添加到收藏夹

Review Multidisciplinary Sciences

T cell exclusion, immune privilege, and the tumor microenvironment

Johanna A. Joyce et al.

SCIENCE (2015)

添加到收藏夹

Article Oncology

Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages

Ling Ding et al.

ONCOTARGET (2015)

添加到收藏夹

Review Cell Biology

Immune microenvironments in solid tumors: new targets for therapy

Stephen L. Shiao et al.

GENES & DEVELOPMENT (2011)

添加到收藏夹

Article Immunology

The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice

Fang Ma et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2010)

添加到收藏夹

Review Biochemistry & Molecular Biology

CD8+ T cell efficacy in vaccination and disease

Victor Appay et al.

NATURE MEDICINE (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

The tumor microenvironment and its role in promoting tumor growth

T. L. Whiteside

ONCOGENE (2008)

添加到收藏夹

Review Dermatology

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

MA Stanley

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2002)

添加到收藏夹

Article Medicine, Research & Experimental

Role of AMP-activated protein kinase in mechanism of metformin action

GC Zhou et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.